Suchergebnisse - "Pappas, Dimitrios A"

PubPharm (10)

1

Anti-citrullinated protein antibody profiles predict changes in disease activity in patients with rheumatoid arthritis initiating biologics

enthalten in: Rheumatology (Oxford, England) | 2024

von Aripova, N. | Kremer, J. | Pappas, D. | +6

2

Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis : An analysis from the CorEvitas RA Registry

enthalten in: Clinical rheumatology | 2023

von Sebba, A. | Bingham, C. | Bykerk, V. | +9

3

The effect of targeted rheumatoid arthritis therapeutics on systemic inflammation and anemia : analysis of data from the CorEvitas RA registry

enthalten in: Arthritis research & therapy | 2022

von Padula, A. | Pappas, D. | Fiore, S. | +4

4

Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis : results from a large US registry study'' by Zheng et al

enthalten in: Annals of the rheumatic diseases | 2022

von Pappas, D. | St John, G. | Etzel, C. | +8

CommentOn: Ann Rheum Dis. 2021 Jan;80(1):96-102. - PMID 32719038

5

Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis

enthalten in: Arthritis care & research | 2021

von Curtis, J. | Palmer, J. | Reed, G. | +4

6

Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis : results from a decision impact study

enthalten in: Rheumatology international | 2021

von Pappas, D. | Brittle, C. | Mossell, J. | +3

7

Associations between an expanded autoantibody profile and treatment responses to biologic therapies in patients with rheumatoid arthritis

enthalten in: International immunopharmacology | 2021

von Petro, A. | Dougherty, J. | England, B. | +9

8

Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy : retrospective analysis of corrona registry data

enthalten in: Rheumatology international | 2021

von Pappas, D. | Litman, H. | Lesperance, T. | +6

9

Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis : results from a large US registry study

enthalten in: Annals of the rheumatic diseases | 2021

von Pappas, D. | St John, G. | Etzel, C. | +8

CommentIn: Ann Rheum Dis. 2022 Nov;81(11):e224. - PMID 33177099

10

enthalten in: Nature reviews. Drug discovery | 2009

von Pappas, D. | Bathon, J. | Hanicq, D. | +2

1
[1]